Literature DB >> 904660

In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.

R P Lisak, B Zweiman.   

Abstract

In an attempt to characterize the immunologic reactivity of cerebrospinal-fluid lymphocytes in demyelinating diseases, we compared the myelin-basic-protein-induced in vitro responses of these cells to peripheral blood lymphocytes from the same subjects with a variety of neurologic diseases. Peripheral blood lymphocytes from patients with acute disseminated encephalomyelitis and progressive multiple sclerosis had increased reactivity as compared to those of normal volunteers (P less than 0.01 and P less than 0.05, respectively). Cerebrospinal-fluid lymphocytes from patients with acute disseminated encephalomyelitis and acute and progressive (but not stable) multiple sclerosis were more reactive than cells from subjects with other neurologic diseases (P less than 0.005, P less than 0.02 and P less than 0.05, respectively). Cerebrospinal-fluid lymphocytes manifested a greater reactivity than peripheral blood lymphocytes in acute and progressive multiple sclerosis but not in acute disseminated encephalomyelitis. These findings demonstrate that lymphocytic cells reactive to myelin basic protein are present in the spinal fluid during active demyelinating disease; and that these cells may be more reactive than peripheral blood lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 904660     DOI: 10.1056/NEJM197710202971602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

Review 1.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.

Authors:  Ameneh Ghaffarinia; Cyrus Jalili; Ali Mostafaie; Shahram Parvaneh; Nafiseh Pakravan
Journal:  Iran J Pathol       Date:  2015

3.  Cold reactive antilymphocyte antibodies in neurological diseases.

Authors:  R P Lisak; F Mercado; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

Review 4.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity.

Authors:  J R Perfect; M M Hobbs; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

Review 6.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

Review 7.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

8.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.

Authors:  J E Merrill; G Biberfeld; S Landin; A Sidén; E Norrby
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

10.  Long-term growth in vitro of human cerebrospinal fluid T lymphocytes.

Authors:  J B Burns; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.